Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma

被引：37

作者：

Kirn, DH

Kramer, A

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1996年 / 88卷 / 11期

关键词：

D O I：

10.1093/jnci/88.11.764-b

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：764 / 765

页数：2

共 15 条

[1] CHEMOTHERAPY OF ADVANCED SOFT-TISSUE SARCOMAS [J].

ANTMAN, KH ;

ELIAS, AD .

SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01) :53-58

[2] INHIBITION OF CELL MOTILITY BY INTERFERON [J].

BROUTYBOYE, D ;

ZETTER, BR .

SCIENCE, 1980, 208 (4443) :516-518

[3] CLINICAL-FEATURES OF MALIGNANT HAEMANGIOPERICYTOMAS AND HEMANGIOENDOTHELIOSARCOMAS [J].

DAUGAARD, S ;

HULTBERG, BM ;

HOUJENSEN, K ;

MOURIDSEN, HT .

ACTA ONCOLOGICA, 1988, 27 (03) :209-213

[4] HEMANGIOPERICYTOMA - ANALYSIS OF 106 CASES [J].

ENZINGER, FM ;

SMITH, BH .

HUMAN PATHOLOGY, 1976, 7 (01) :61-82

[5] INTERFERON ALFA-2A THERAPY FOR LIFE-THREATENING HEMANGIOMAS OF INFANCY [J].

EZEKOWITZ, RAB ;

MULLIKEN, JB ;

FOLKMAN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) :1456-1463

[6]

EZEKOWITZ RAB, 1995, NEW ENGL J MED, V333, P595

[7] MENINGEAL HEMANGIOPERICYTOMA - HISTOPATHOLOGICAL FEATURES, TREATMENT, AND LONG-TERM FOLLOW-UP OF 44 CASES [J].

GUTHRIE, BL ;

EBERSOLD, MJ ;

SCHEITHAUER, BW ;

SHAW, EG .

NEUROSURGERY, 1989, 25 (04) :514-522

[8]

KARPEH MS, 1991, ARCH SURG-CHICAGO, V126, P1474

[9] INTERFERON-ALPHA WITH ZIDOVUDINE - SAFETY, TOLERANCE, AND CLINICAL AND VIROLOGICAL EFFECTS IN PATIENTS WITH KAPOSI-SARCOMA ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) [J].

KROWN, SE ;

GOLD, JWM ;

NIEDZWIECKI, D ;

BUNDOW, D ;

FLOMENBERG, N ;

GANSBACHER, B ;

BREW, BJ .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (11) :812-821

[10]

KROWN SE, 1990, ANN INTERN MED, V113, P334, DOI 10.7326/0003-4819-113-4-334_1

← 1 2 →